Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has actually made an overdue entrance to the radioligand event, paying out one hundred thous...

F 2G rears $100M for 2nd try to receive brand-new antifungal to market

.After F2G's initial attempt to get a new training class of antifungal to market was thwarted by the...

Moderna targets $1.1 B in R&ampD spending slices, falls 5 courses amid profits tensions

.Moderna has sworn to cut R&ampD investing through $1.1 billion through 2027. The choice to shrink t...

Sanofi's $80M bet on Key dystrophy medicine finishes in phase 3 lose big

.Just four months after Sanofi bet $80 million in ahead of time cash on Key Therapeutics' losmapimod...

Oncternal stock drains 60% amid layoffs, test firings

.Cancer company Oncternal Therapies is folding all its medical tests and also giving up workers, tra...

Roche is actually holding out hopes that its injectable weight problems prospect could ultimately illustrate 25% weight reduction in late-stage test

.Roche is actually holding out chances that its injectable excessive weight possibility might ultima...

Novo Nordisk barrages 'impressive' weight loss result for dual-acting oral medication in early trial

.Novo Nordisk has actually raised the lid on a period 1 test of its own oral amylin as well as GLP-1...

AbbVie sues BeiGene over blood cancer drug secret method

.Simply a handful of brief full weeks after winning an FDA Fast Track tag for its investigational BT...

Lilly delivers one-two punch along with second tranche of favorable data on weekly blood insulin applicant

.Not long after a favorable data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based compan...

BridgeBio cuts genetics therapy budget as professional information let down

.BridgeBio Pharma is actually lowering its genetics treatment budget plan as well as pulling back fr...